BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 27260388)

  • 1. Interleukins 1 and 6 as Main Mediators of Inflammation and Cancer.
    Dmitrieva OS; Shilovskiy IP; Khaitov MR; Grivennikov SI
    Biochemistry (Mosc); 2016 Feb; 81(2):80-90. PubMed ID: 27260388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis.
    Chen XW; Zhou SF
    Drug Des Devel Ther; 2015; 9():2941-6. PubMed ID: 26089643
    [No Abstract]   [Full Text] [Related]  

  • 3. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.
    Taniguchi K; Karin M
    Semin Immunol; 2014 Feb; 26(1):54-74. PubMed ID: 24552665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation amplifier, a new paradigm in cancer biology.
    Atsumi T; Singh R; Sabharwal L; Bando H; Meng J; Arima Y; Yamada M; Harada M; Jiang JJ; Kamimura D; Ogura H; Hirano T; Murakami M
    Cancer Res; 2014 Jan; 74(1):8-14. PubMed ID: 24362915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-23 promotes tumour incidence and growth.
    Langowski JL; Zhang X; Wu L; Mattson JD; Chen T; Smith K; Basham B; McClanahan T; Kastelein RA; Oft M
    Nature; 2006 Jul; 442(7101):461-5. PubMed ID: 16688182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wogonin suppresses human alveolar adenocarcinoma cell A549 migration in inflammatory microenvironment by modulating the IL-6/STAT3 signaling pathway.
    Zhao Y; Yao J; Wu XP; Zhao L; Zhou YX; Zhang Y; You QD; Guo QL; Lu N
    Mol Carcinog; 2015 Jun; 54 Suppl 1():E81-93. PubMed ID: 24976450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-8 and interleukin-17 for cancer.
    Zarogoulidis P; Katsikogianni F; Tsiouda T; Sakkas A; Katsikogiannis N; Zarogoulidis K
    Cancer Invest; 2014 Jun; 32(5):197-205. PubMed ID: 24669909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation-induced inflammatory cascade and its reverberating crosstalks as potential cause of post-radiotherapy second malignancies.
    Gandhi S; Chandna S
    Cancer Metastasis Rev; 2017 Jun; 36(2):375-393. PubMed ID: 28707199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Elicited Inflammation and Colorectal Cancer.
    Wang K; Karin M
    Adv Cancer Res; 2015; 128():173-96. PubMed ID: 26216633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and lung carcinogenesis: applying findings in prevention and treatment.
    Peebles KA; Lee JM; Mao JT; Hazra S; Reckamp KL; Krysan K; Dohadwala M; Heinrich EL; Walser TC; Cui X; Baratelli FE; Garon E; Sharma S; Dubinett SM
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1405-21. PubMed ID: 17944566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central Roles of STAT3-Mediated Signals in Onset and Development of Cancers: Tumorigenesis and Immunosurveillance.
    Hashimoto S; Hashimoto A; Muromoto R; Kitai Y; Oritani K; Matsuda T
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-κB and the link between inflammation and cancer.
    DiDonato JA; Mercurio F; Karin M
    Immunol Rev; 2012 Mar; 246(1):379-400. PubMed ID: 22435567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment.
    Atretkhany KN; Drutskaya MS; Nedospasov SA; Grivennikov SI; Kuprash DV
    Pharmacol Ther; 2016 Dec; 168():98-112. PubMed ID: 27613100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fundamental role of mechanical properties in the progression of cancer disease and inflammation.
    Mierke CT
    Rep Prog Phys; 2014 Jul; 77(7):076602. PubMed ID: 25006689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-related interleukins: old validated targets for new anti-cancer drug development.
    Setrerrahmane S; Xu H
    Mol Cancer; 2017 Sep; 16(1):153. PubMed ID: 28927416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose Tumor Microenvironment.
    Zewdu A; Casadei L; Pollock RE; Braggio D
    Adv Exp Med Biol; 2020; 1226():73-86. PubMed ID: 32030677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between inflammation and cancer.
    Khandia R; Munjal A
    Adv Protein Chem Struct Biol; 2020; 119():199-245. PubMed ID: 31997769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
    Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
    Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-related inflammation.
    Candido J; Hagemann T
    J Clin Immunol; 2013 Jan; 33 Suppl 1():S79-84. PubMed ID: 23225204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular link mechanisms between inflammation and cancer.
    Vendramini-Costa DB; Carvalho JE
    Curr Pharm Des; 2012; 18(26):3831-52. PubMed ID: 22632748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.